TrialPloS one2016

Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.

Perica Davitkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.